Antibodies.Com 3C8N.1, Anti-Wilms Tumour Protein Antibody

The Antibodies.Com 3C8N.1 is designed for the detection and study of Wilms tumour protein 1 (WT1), a transcription factor involved in cellular development and differentiation. It provides researchers with a targeted antibody reagent for investigating WT1 expression in biological samples and experimental workflows. It can be incorporated into compatible antibody-based laboratory workflows that require selective detection and analysis of Wilms tumour protein.

Targeted WT1 Recognition

Developed to recognise Wilms tumour protein, the 3C8N1 antibody supports selective investigation of WT1 in research samples. This target specificity makes it useful when examining protein expression, localisation, and WT1-associated cellular processes.

Key Research Benefits of the Product

• Targets Wilms tumour protein 1 (WT1).
• Supports WT1 protein detection and analysis.
• Suitable for laboratory research workflows.
• Helps investigate WT1 expression in biological samples.
• Useful for protein localisation and expression studies.
• Designed for consistent experimental use.

Versatile Uses of the 3C8N.1 Anti-Wilms Tumour Protein Antibody

The 3C8N.1 can support research across areas such as:

• Cancer and tumour biology research
• WT1 expression studies
• Molecular and cellular biology
• Protein detection and localisation
• Developmental biology research
• Biomarker-focused investigations